Incyte (INCY) FY2015 results: revenue $754 million, up 47.4% on the year
Incyte Corp. (INCY) reported revenue of $754 million for fiscal 2015, the year ended 31 December 2015, up 47.4% on the year before. Net income was $7 million, and diluted earnings per share $0.03. The figures are the company's own, from the 10-K it filed with the SEC on 12 February 2016.
Revenue
$754 million
+47.4% on the year
FY2009FY2015
Operating margin
6.7%
-0.9% a year earlier
FY2009FY2015
Net income
$7 million
FY2009FY2015
Diluted EPS
$0.03
FY2009FY2015
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Revenue
754
511
355
+47.4%
Cost of revenue
27.0
3.0
0.6
+797.9%
Gross profit
727
508
354
+42.9%
Gross margin
96.4%
99.4%
99.8%
Research and development
480
348
260
+38.0%
Selling, general and administrative
197
166
110
+18.6%
Operating income
50.7
-4.8
-16.1
Operating margin
6.7%
-0.9%
-4.5%
Interest expense
45.6
46.8
38.7
-2.6%
Pre-tax income
7.6
-48.5
-82.8
Income tax
1.0
-0.1
0.3
Effective tax rate
13.6%
n/a
n/a
Net income
6.5
-48.5
-83.1
Net margin
0.9%
-9.5%
-23.4%
Diluted EPS
$0.03
-$0.29
-$0.56
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Operating cash flow
89.4
26.3
9.2
+240.5%
Capital expenditure
26.0
27.9
4.3
-6.7%
Free cash flow
63.4
-1.6
4.9
Free cash flow margin
8.4%
-0.3%
1.4%
Cash from investing
-105
n/a
n/a
Cash from financing
84.7
n/a
n/a
Depreciation and amortisation
44.9
41.4
29.2
+8.4%
Share-based compensation
69.9
62.2
38.4
+12.4%
Diluted shares, weighted
187m
168m
148m
+11.5%
Shares outstanding at period end
187m
171m
163m
+9.2%
Balance sheet
$ million
FY2015
FY2014
FY2013
On the year
Last 8 years
Shareholders' equity
171
-81.6
-193
Debt
750
841
847
-10.8%
Other liabilities
86.5
37.2
n/a
+132.5%
Total liabilities and equity
1,007
796
630
+26.5%
Fixed assets
86.0
81.8
26.8
+5.2%
Intangible assets
12.3
2.0
17.5
+503.1%
Investments
222
148
37.6
+49.8%
Cash and equivalents
521
452
471
+15.3%
Inventory
1.8
0.4
0.4
+398.0%
Other assets
164
112
75.8
+46.7%
Total assets
1,007
796
630
+26.5%
10-K for the year ended 31 December 2015, filed 12 February 2016: the filing.